BioNxt Solutions Inc.
BNXTF
$0.46
$0.024.07%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.20K | -- | -- | 3.30K | 12.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.20K | -- | -- | 3.30K | 12.50K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 8.20K | -- | -- | 3.30K | 12.50K |
| SG&A Expenses | 823.80K | 550.80K | 1.17M | 589.30K | 612.70K |
| Depreciation & Amortization | 4.00K | 4.90K | -4.10K | 16.30K | 16.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 927.80K | 784.00K | 1.28M | 769.70K | 979.90K |
| Operating Income | -919.70K | -784.00K | -1.28M | -766.40K | -967.40K |
| Income Before Tax | -1.16M | -939.80K | -1.38M | -991.00K | -1.07M |
| Income Tax Expenses | -- | -- | -- | -64.10K | -- |
| Earnings from Continuing Operations | -1.16M | -939.80K | -1.38M | -926.80K | -1.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.16M | -939.80K | -1.38M | -926.80K | -1.07M |
| EBIT | -919.70K | -784.00K | -1.28M | -766.40K | -967.40K |
| EBITDA | -915.60K | -779.10K | -1.26M | -750.10K | -950.50K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 117.65M | 116.08M | 115.37M | 113.38M | 113.02M |
| Average Diluted Shares Outstanding | 117.65M | 116.08M | 115.37M | 113.38M | 113.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |